Weekly Digest - November 2024
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
Weekly Digest - November 2024
8 Nov 2024: ENHERTU Receives Prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
- ENHERTU® (fam-trastuzumab deruxtecan-nxki), developed by Daiichi Sankyo and AstraZeneca, has won the prestigious 2024 Prix Galien USA Award for Best Biotechnology Product
- The award recognizes ENHERTU’s innovative development as a HER2-directed DXd ADC, which has transformed the treatment of HER2-positive cancers, particularly metastatic breast cancer
- ENHERTU has had a major impact on the treatment landscape, particularly with its tumor-agnostic approval in the U.S. earlier this year, allowing it to treat a broader range of HER2-positive solid tumors
- Daiichi Sankyo and AstraZeneca continue to pursue innovative clinical research for ENHERTU, with the goal of expanding its use to further improve cancer treatment worldwide
